Entacapone and prostate cancer risk in patients with Parkinson's disease.
Korhonen P, Kuoppamäki M, Prami T, Hoti F, Christopher S, Ellmén J, Aho V, Vahteristo M, Pukkala E, Haukka J.
Korhonen P, et al. Among authors: kuoppamaki m.
Mov Disord. 2015 Apr 15;30(5):724-8. doi: 10.1002/mds.26140. Epub 2015 Jan 16.
Mov Disord. 2015.
PMID: 25639262